Shionogi Highlights Real-World Effectiveness of Fetroja/Fetcroja Against MBL-Producing Enterobacterales at ESCMID Global 2026 Shionogi & Co., Ltd. has unveiled new real-world and surveillance data highlighting the clinical utility of cefiderocol (marketed as Fetroja®/Fetcroja®) in the treatment of highly resistant Gram-negative…
Acadia Pharmaceuticals Expands U.S. Access to DAYBUE STIX for Patients with Rett Syndrome Acadia Pharmaceuticals has announced that DAYBUE® STIX (trofinetide) for oral solution—a newly developed powder formulation of its Rett syndrome therapy—is now broadly available across the United States.…
Endospan Secures U.S. Food and Drug Administration Approval for NEXUS® Aortic Arch Stent Graft System Endospan, a privately held innovator focused on advancing endovascular therapies for complex aortic conditions, has announced a major regulatory milestone with the approval of its…
Alcon Introduces Clareon TruPlus Monofocal and Toric IOLs Featuring Advanced Design Innovations at ASCRS 2026 Alcon a global leader in eye care committed to advancing vision health and improving patient outcomes, has announced the U.S. launch of its latest intraocular…
Affinia Therapeutics Secures Health Canada Clearance to Launch UPBEAT© Phase 1/2 Trial Evaluating AFTX-201 for BAG3-Related Dilated Cardiomyopathy Affinia Therapeutics, a clinical-stage biotechnology company focused on advancing next-generation gene therapies for serious cardiovascular diseases, has announced a key regulatory milestone…
Armatus Reports Promising Breakthrough Data on TVR110, a Vectorized MicroRNA Therapy for Charcot-Marie-Tooth Disease Type 1A Armatus Bio, a late-preclinical biotechnology company focused on developing next-generation vectorized RNA interference (RNAi) therapies for neuromuscular disorders, has announced the publication of important…
Curve Biosciences Announces Appointment of Dr. Amit Singal as Chief Medical Officer Curve Biosciences, a company focused on advancing innovative approaches to whole-body intelligence in healthcare, has announced the appointment of Amit Singal, M.D., as its new Chief Medical Officer.…
PharmaEssentia Announces Investment Agreement to Build New Manufacturing Facility in Puerto Rico PharmaEssentia Corporation, a global biopharmaceutical company headquartered in Taiwan, has taken a significant step in expanding its international manufacturing footprint with the signing of an investment agreement for…
Shape Memory Medical Initiates Patient Enrollment in FLAGSHIP Study of Novel False Lumen Embolization Technology Shape Memory Medical Inc. has announced a major clinical milestone with the enrollment of the first patients in its FLAGSHIP study, a first-in-human clinical trial…
Gilead Extends Tender Offer Timeline for Planned Acquisition of Arcellx Gilead Sciences, Inc. has announced an extension of its ongoing tender offer to acquire all outstanding shares of common stock of Arcellx, signaling continued progress in one of the more…
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial Evaluating BOT+BAL Combination in MSS/pMMR Metastatic Colorectal Cance Agenus Inc., a clinical-stage immuno-oncology company focused on developing novel therapies to address hard-to-treat cancers, has announced a significant milestone in…
Lilly Announces Acquisition of Centessa Pharmaceuticals to Expand Pipeline in Sleep-Wake Disorder Treatments Eli Lilly and Company and Centessa Pharmaceuticals plc have announced a definitive agreement under which Lilly will acquire Centessa in a transaction that underscores the growing strategic…